NCT05787964View on ClinicalTrials.gov

Immunity to Infection in Healthy Participants and Participants With Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

September 1, 2024

Study Completion Date

September 1, 2024

Conditions
InfluenzaSARS-CoV-2Hematologic MalignancySolid Tumor
Interventions
PROCEDURE

Biological sample collection

Whole blood (blood draw/phlebotomy) will be obtained to proceed with immunologic analysis of samples. Collection of biologic samples will occur up to 12 months.

Trial Locations (1)

72076

University Hopsital Tuebingen, Tübingen

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER